- ►nih.gov D Patsouris, S Mandard, PJ Voshol, P Escher, … - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig 1 Nutrition, Metabolism and Genomics Group, Division of Human Nutrition,
Wageningen University, Wageningen, The Netherlands. 2 Department of
Endocrinology and Diabetes, Leiden University Medical Center, Leiden, The ... Cited by 92 - Related articles - BL Direct - All 8 versions
B Fagerberg, S Edwards, T Halmos, J … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 1716–1725 DOI 10.1007/s00125-005-1846-8 ARTICLE
B. Fagerberg . S. Edwards . T. Halmos . J. Lopatynski . H. Schuster . ... Cited by 72 - Related articles - All 5 versions
A Bernardo, L Minghetti - Current Pharmaceutical Design, 2006 - ingentaconnect.com Abstract: The peroxisome proliferator-activated receptor-γ (PPAR-γ) belongs to
a large group of nuclear receptors controlling reproduction, metabolism,
development and immune response. Upon activation by specific agonists, ... Cited by 58 - Related articles - BL Direct - All 5 versions
CW Park, Y Zhang, X Zhang, J Wu, L Chen, DR … - Kidney International, 2006 - nature.com Peroxisome proliferator-activated receptor (PPAR ) is a member of the
ligand-activated nuclear receptor superfamily, and plays an important role in
lipid metabolism and glucose homeostasis. The purpose of this study is to ... Cited by 39 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org A Hiuge, A Tenenbaum, N Maeda, M Benderly, … - Arteriosclerosis, thrombosis, and vascular biology, 2007 - Am Heart Assoc From Department of Metabolic Medicine (AH, NM, MK, TH, KF, HN, SK, IS, TF),
Graduate School of Medicine, Osaka University, Osaka, Japan; Cardiac
Rehabilitation Institute (AT, EZF, YA, MM), The Israel Society for the ... Cited by 37 - Related articles - All 8 versions
LC Pickavance, CL Brand, K Wassermann, … - British journal of pharmacology, 2005 - pubmedcentral.nih.gov Insulin sensitivity was improved equally by RAGA and PIO in fa/fa rats subjected
to both prevention and intervention treatments (eg, prevention HOMA-IR: −71
and −72%, respectively), as was hyperglycaemia (both −68%). BF had no ... Cited by 35 - Related articles - All 5 versions
- ►ahajournals.org K Araki, T Masaki, I Katsuragi, K Tanaka, T … - Hypertension, 2006 - Am Heart Assoc The aim of the present study was to clarify the effect of telmisartan, an
angiotensin II receptor blocker, on the development of obesity and related
metabolic disorders in diet-induced obese mice. Treatment with telmisartan ... Cited by 31 - Related articles - All 10 versions
B Thorens, PJ Larsen - Current Opinion in Clinical Nutrition & Metabolic Care, 2004 - journals.lww.com Purpose of review The control of glucose and energy homeostasis, including
feeding behaviour, is tightly regulated by gut-derived peptidic and nonpeptidic
endocrine mediators, autonomic nervous signals, as well as nutrients such ... Cited by 27 - Related articles - BL Direct - All 2 versions
FL Egerod, HS Nielsen, L Iversen, I Thorup, T … - Biomarkers, 2005 - informahealthcare.com Small-molecule agonists of the peroxisome proliferator-activated receptor (PPAR)
α and γ isoforms (dual-acting PPAR agonists) can cause urothelial cancers in
rodents. Rats were dosed orally for 16 days with bladder carcinogenic ( ... Cited by 26 - Related articles - BL Direct - All 7 versions
- ►clonegenbiotech.com [PDF] RAK Srivastava, R Jahagirdar, S Azhar, S … - Molecular and cellular biochemistry, 2006 - Springer Page 1. Molecular and Cellular Biochemistry 285: 35–50, 2006. DOI: 10.1007/s11010-
005-9053-y c g Springer 2006 Peroxisome proliferator-activated receptor-α ... Cited by 25 - Related articles - BL Direct - All 7 versions
